What's new

Summary of opinion: Pemazyre, 27/03/2025 Negative

Summary of opinion: Pemazyre, 27/03/2025 Negative

Mar 28, 2025 - 12:00
 0
Summary of opinion: Pemazyre, 27/03/2025 Negative
Summary of opinion: Pemazyre, 27/03/2025 Negative
Read More

Tags:

Previous Article

EMA concludes review of weight management medicine Mysimba

Next Article

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab,...

Related Posts

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0

EMEA-000205-PIP02-11-M06

EMEA-000205-PIP02-11-M06

Mar 13, 2025  0

EMEA-003025-PIP03-23-M01

EMEA-003025-PIP03-23-M01

Feb 13, 2025  0